Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability

Mehmet Kanbay1, Bunyamin Isik, Ali Akcay

  • 1Department of Internal Medicine, Section of Nephrology, Fatih University Faculty of Medicine, Ankara, Turkey. mkanbay@fatih.edu.tr

Insights

Higher phosphate and parathyroid hormone (PTH) levels are linked to nondipper hypertension in patients with normal kidney function. This suggests a connection between mineral metabolism and abnormal blood pressure patterns, even without kidney disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Abnormal circadian blood pressure is linked to bone and mineral metabolism issues in renal disease.
  • This association has not been previously reported in hypertensive patients with normal renal function.

Purpose of the Study:

  • To investigate the association between serum phosphate, calcium, parathyroid hormone (PTH), and the calcium x phosphate (Ca x P) product with nondipper hypertension.
  • To evaluate these factors in hypertensive patients with normal renal function and no PTH disorders.

Main Methods:

  • 190 hypertensive patients with normal phosphate and PTH levels were enrolled.
  • Inclusion criteria included a glomerular filtration rate (GFR) >60 ml/min and no history of calcium, phosphate, vitamin D medication, or hyperparathyroidism.

Main Results:

  • Nondipper patients (60%) exhibited higher phosphate, Ca x P product, and PTH levels compared to dipper patients (40%).
  • Parathyroid hormone (PTH) and phosphate were identified as independent predictors of nondipper hypertension.

Conclusions:

  • A relationship exists between elevated phosphate, PTH, and Ca x P product and the risk of nondipping in hypertensive individuals.
  • This finding highlights the importance of mineral metabolism in the development of abnormal circadian blood pressure profiles, even in the absence of renal disease.
Abstract

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...